Compared to Semaglutide and Tirzepatide, retatrutide's distinctive inclusion of glucagon receptor agonism along with GIP and GLP-1 receptor agonism provides a definite pharmacological profile. Though Semaglutide is often a GLP-1 receptor agonist and Tirzepatide combines GLP-1 and GIP receptor agonism, retatrutide's triple system could potentially deliver broader metabolic Gains. https://corepepptides.com/product/retatrutide-injection-pen/